Evolus

Bio & Pharma Medytox to sell off 2.2 mn shares of Daewoong's American partner Evolus

Medytox Inc. said in a regulatory filing on Wednesday that it is selling off approximately 2.19 million shares of Evolus, Daewoong Pharmaceutical's ...

Bio & Pharma Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect

Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...